论文部分内容阅读
体外反搏作为辅助循环装置应用于冠心病,心源性休克已有十余年,取得了一定疗效。蛇毒抗栓酶(以下简称蛇毒)作为新近发现的溶栓制剂用于闭塞性脑血管病也取得满意效果。根据蛇毒的溶栓机理及体外反搏能提高主动脉舒张压,增加冠状动脉血流的原理,我院于1988年5月至1990年11月将二者联合用于冠心病心绞痛,并与消心痛等药物治疗在预防心绞痛发作,控制病情发展及改善心电图方面进行了疗效比较。现将观察结果报道如下。
Extracorporeal counterpulsation as a secondary circulatory device applied to coronary heart disease, cardiogenic shock for more than ten years, and achieved a certain effect. Snake venom antithrombotic enzyme (hereinafter referred to as snake venom) as a newly discovered thrombolytic agent for obliterative cerebrovascular disease also achieved satisfactory results. According to the thrombolytic mechanism of snake venom and external counterpulsation can increase the aortic diastolic blood pressure, increase the principle of coronary blood flow, our hospital from May 1988 to November 1990 the two combined for angina pectoris and elimination Heartache and other drug treatment in the prevention of angina pectoris, control of disease progression and improvement of the electrocardiogram were compared. The observations are reported below.